Targeted Medical (TRGM)

Targeted Medical Pharma, Inc. is a healthcare company listed on OTC Markets as common stock under the ticker TRGM. Doing business as Physician Therapeutics, the company develops and commercializes amino acid-based medications in the United States for physicians, pharmacies, and patients. Its product portfolio includes patented amino acid-based medical foods, dietary supplements, and generic drugs aimed at a range of conditions, including metabolic syndrome and obesity, sleep disorders linked to anxiety or depression, hypertension, viral infections, cognitive disorders and fatigue, fibromyalgia, PTSD, pain and inflammatory conditions, osteoarthritis and joint disorders, and peripheral neuropathy.

In addition to its products, the company provides PDRx, a proprietary billing process and software platform that supports physician dispensing, inventory control, and regulatory reporting. Targeted Medical Pharma also handles billing and collections for dispensing physician clients in connection with private insurance and workers’ compensation claims. The company distributes its products through distributors and an internal sales force, was founded in 1996, and is headquartered in Los Angeles, California. It previously operated under the name Targeted Medical Foods before adopting its current name in 2006.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.